Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|June 15, 1999
Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposideM J Elliott, K M Murphy, L Stribinskiene, et al.
Cancer Research|November 15, 1988
Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase IR S Gupta, R Gupta, B Eng, et al.
Cancer Chemotherapy and Pharmacology|August 14, 1999
Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIalpha and betaR M Turnbull, E L Meczes, M Perenna Rogers, et al.
Oncogene|June 2, 2009
Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptaseJ Yuan, B M-P Yang, Z-H Zhong, et al.
Leukemia|January 11, 2013
Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemiaS H Oram, J Thoms, J I Sive, et al.
Blood Cancer Journal|August 2, 2014
A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemiaA L Samuels, A H Beesley, B D Yadav, et al.
British Journal of Cancer|November 27, 2001
MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cellsA E Peaston, M Gardaneh, A V Franco, et al.
Ebiomedicine|November 3, 2018
The Avatar Acceptability Study: Survivor, Parent and Community Willingness to Use Patient-Derived Xenografts to Personalize Cancer CareC E Wakefield, E L Doolan, J E Fardell, et al.
Leukemia|December 12, 2012
FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradationA Malyukova, S Brown, R Papa, et al.
Oncogene|August 3, 2010
A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patientsS H Oram, J A I Thoms, C Pridans, et al.
Pageof 4